Anti-depressant Esketamine could be approved for use in UK
J&J wins partial appeal against U.K.'s cost-effectiveness watchdog
First Esketamine nasal spray session in the UK private sector - London TMS Centre
Ketamine-like drug for depression could get UK licence within the year | Drugs | The Guardian
Ketamine-related drug could be 'watershed' in treating depression | Depression | The Guardian
Ketamine Therapy for Depression in Long Beach California - PACIFIC MIND HEALTH
Esketamine antidepressant nasal spray rejected by NICE - Pulse Today
Janssen's esketamine nasal spray not recommended by NICE for NHS use - Pharmaceutical Technology
NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination | Daily Mail Online
Antidepressant nasal spray approved for use in Scotland
Ketamine nasal spray rapidly relieves depression and suicidal thoughts, finds trial | The Independent | The Independent
NICE's rebuff of J&J depression nasal spray under scrutiny
UK Assessment Agency Rejects Spravato Ketamine Nasal Spray - Psychedelic Science Review
Ketamine-based drug 'licensed for use in UK to treat depression' | Metro News
PDF) Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance
NICE does not recommend esketamine for treatment-resistant depression
First Esketamine nasal spray session in the UK private sector - London TMS Centre
esketamine nasal spray for treatment-resistant depression
NHS rejects ketamine for depression as psychiatrists accuse NICE of mental health discrimination | Daily Mail Online
Ketamine-like drug for depression gets UK licence | Medical research | The Guardian
Esketamine (Spravato®) nasal spray for depression - London TMS Centre
Esketamine spray for treating depression 'not cost-effective' - BBC News
Spravato 28 mg nasal spray, solution - Summary of Product Characteristics (SmPC) - (emc)
JanssenUS on Twitter: "#APAAM19 attendees: Don't miss the dosing and administration demos for SPRAVATO™ (esketamine) CIII Nasal Spray happening Sunday-Tuesday at booth 1731! See full PI, including Boxed WARNINGS: https://t.co/DkLEk95oZc https://t.co ...
Esketamine: US regulator approves nasal spray to treat depression - BBC News
Esketamine spray for treating depression 'not cost-effective' - BBC News
